<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Verna G</submitter><funding>NIDDK NIH HHS</funding><funding>NIDDK</funding><pagination>e196712</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12721895</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(1)</volume><pubmed_abstract>Colitis-associated cancer (CAC) arises from a complex interplay between host and environmental factors. In this report, we investigated the role of the gut microbiome using Winnie mice, an ulcerative colitis-like (UC-like) model with a missense mutation in the Muc2 gene. Upon rederivation from a conventional (CONV) to a specific pathogen-free (SPF) facility, Winnie mice developed severe colitis and, notably, spontaneous CAC that progressively worsened over time. In contrast, CONV Winnie mice showed only mild colitis but no tumorigenesis. By comparison, when re-derived into germ-free (GF) conditions, SPF Winnie mice were protected from colitis and colon tumors, indicating an essential role for the gut microbiome in the development of CAC in these mice. Using shotgun metagenomics, metabolomi</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>A missense mutation in Muc2 promotes gut microbiome and metabolome-dependent colitis-associated tumorigenesis.</pubmed_title><pmcid>PMC12721895</pmcid><funding_grant_id>DK042191</funding_grant_id><funding_grant_id>R56 DK042191</funding_grant_id><funding_grant_id>R56 DK055812</funding_grant_id><funding_grant_id>R37 DK042191</funding_grant_id><funding_grant_id>DK019222</funding_grant_id><funding_grant_id>R01 DK055812</funding_grant_id><funding_grant_id>R01 DK042191</funding_grant_id><funding_grant_id>DK055812</funding_grant_id><pubmed_authors>Miller EN</pubmed_authors><pubmed_authors>Pizarro TT</pubmed_authors><pubmed_authors>Chieppa M</pubmed_authors><pubmed_authors>Islam BN</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>De Almeida Celio F</pubmed_authors><pubmed_authors>Cominelli F</pubmed_authors><pubmed_authors>Sommella EM</pubmed_authors><pubmed_authors>Verna G</pubmed_authors><pubmed_authors>Licastro D</pubmed_authors><pubmed_authors>Merciai F</pubmed_authors><pubmed_authors>Xin W</pubmed_authors><pubmed_authors>De Santis S</pubmed_authors><pubmed_authors>Caponigro V</pubmed_authors><pubmed_authors>Campiglia P</pubmed_authors></additional><is_claimable>false</is_claimable><name>A missense mutation in Muc2 promotes gut microbiome and metabolome-dependent colitis-associated tumorigenesis.</name><description>Colitis-associated cancer (CAC) arises from a complex interplay between host and environmental factors. In this report, we investigated the role of the gut microbiome using Winnie mice, an ulcerative colitis-like (UC-like) model with a missense mutation in the Muc2 gene. Upon rederivation from a conventional (CONV) to a specific pathogen-free (SPF) facility, Winnie mice developed severe colitis and, notably, spontaneous CAC that progressively worsened over time. In contrast, CONV Winnie mice showed only mild colitis but no tumorigenesis. By comparison, when re-derived into germ-free (GF) conditions, SPF Winnie mice were protected from colitis and colon tumors, indicating an essential role for the gut microbiome in the development of CAC in these mice. Using shotgun metagenomics, metabolomi</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T09:17:53.331Z</modification><creation>2026-07-02T03:08:59.404Z</creation></dates><accession>S-EPMC12721895</accession><cross_references><pubmed>41196658</pubmed><doi>10.1172/JCI196712</doi></cross_references></HashMap>